Novasil Plus Antacid Suspension
Out of date information, search anotherSUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Novasil Plus Antacid Suspension Lloyds Antacid Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Dried aluminium hydroxide gel BP 200mg/5ml Magnesium hydroxide BP 200mg/5ml Simethicone USP 25mg/5ml
3 PHARMACEUTICAL FORM
Oral suspension.
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
Antacid-deflatulent for the treatment of indigestion, heartburn, wind and dyspepsia.
4.2 Posology and method of administration
Oral
Adults, the elderly and children over 12 years: one to two 5ml spoonfuls twenty minutes to one hour after meals and at bedtime if required.
Not to be given to children under 12 years of age except on the advice of a doctor.
4.3 Contraindications
Novasil Plus Antacid Suspension should not be taken by patients who are severely debilitated or suffering from kidney failure.
4.4 Special warnings and precautions for use
If you are taking any other medicine, consult your doctor or pharmacist before taking this product.
If symptoms persist, consult your doctor.
Keep out of the reach of children.
4.5 Interaction with other medicinal products and other forms of interaction
If taken simultaneously with cimetidine, it can reduce the absorption of this drug. It can also reduce or delay the absorption of the following drugs: mexilitine, diflunisal, chlorpromazine, ketoconazole, pivampicillin and tetracycline.
4.6 Pregnancy and lactation
Novasil Plus Antacid Suspension can be used in pregnancy. (General literature indicates no adverse effects for the active ingredients of Novasil Plus Antacid Suspension on pregnancy or on the health of the foetus/newborn child).
4.7 Effects on ability to drive and use machines
None stated.
4.8 Undesirable effects
None stated.
4.9 Overdose
Serious symptoms are unlikely to follow overdose.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Antacid, deflatulent
5.2 Pharmacokinetic properties
None stated.
5.3 Preclinical safety data
None stated
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Sodium carboxymethylcellulose 7 MF, avicel RC 501, peppermint oil, methyl hydroxybenzoate, propyl hydroxybenzoate, alcohol 96%, chloroform, sodium cyclamate 1968, sodium saccharin, sorbitol solution, water.
6.2 Incompatibilities
None stated.
6.3 Shelf life
24 months unopened. 28 days after opening.
6.4 Special precautions for storage
Store below 25°C. Do not freeze. Discard four weeks after opening.
6.5 Nature and contents of container
100ml, 140ml, 150ml, 200ml, 300ml: amber glass bottles with polypropylene caps in cartons.
6.6 Special precautions for disposal
None.
MARKETING AUTHORISATION HOLDER
7
Ayrton Saunders Ltd
9 Arkwright Road
Astmoor Industrial Estate
Runcorn
Cheshire
WA7 1NU
8 MARKETING AUTHORISATION NUMBER(S)
PL 16431/0095
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
30 January 1990 / 19 June 1996
10 DATE OF REVISION OF THE TEXT
25/01/2011